{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:32:41Z","timestamp":1787758361465,"version":"build-2784847793"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The present study was aimed to evaluate the efficacy of 1.2% Atorvastatin (ATV) with 1.2% Rosuvastatin (RSV) as local drug delivery for treatment of Chronic Periodontitis (CP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Forty patients were equally divided into two groups. Group A underwent scaling and root debridement and 1.2% ATV gel (1.2 mg\/0.1 mL) was placed, whereas group B received scaling and root debridement and RSV (1.2 mg\/0.1 ml) was placed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The results showed that both the groups had improvement in all the recorded parameters, and the results obtained were statistically significant. When comparison was made between the groups, no significant difference was obtained between atorvastatin and rosuvastatin at baseline in all recorded parameters. However, after 6 months significant improvement was recorded in CAL (Clinical attachment level) and PD (Probing depth). The plaque index (PI) and gingival index (GI) score however showed improvement, but it did not attain the level of significance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The present study showed improvement in clinical parameters with the use of ATV and RSV gel when used in combination with scaling and root planing (SRP) in CP patients. Patients with RSV gel showed up significantly better than the ones in which ATV gel was placed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijdr.ijdr_25_21","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T07:01:35Z","timestamp":1665644495000},"page":"180-183","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Comparative Effect of 1.2% Atorvastatin Gel and 1.2% Rosuvastatin as a Local Drug Delivery in Treatment of Intra-Bony Defects in Chronic Periodontitis"],"prefix":"10.4103","volume":"33","author":[{"given":"Ashish","family":"Soni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmikant","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas Chandra","family":"Agrahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20240828","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0757.2005.00113.x","article-title":"Porphyromonasgingivalis, treponemadenticola, and tannerella forsythia: The 'redcomplex', A prototype polybacterial pathogenic consortium in periodontitis","volume":"38","author":"Holt","year":"2005","journal-title":"Periodontol 2000"},{"key":"R3-14-20240828","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/1735-3327.113319","article-title":"The pleotropic role of statins: Could it be the imminent host modulation agent in periodontics?","volume":"10","author":"Grover","year":"2013","journal-title":"Dent Res J (Isfahan"},{"key":"R4-14-20240828","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0757.2010.00347.x","article-title":"Mechanisms and control of pathologic bone loss in periodontitis","volume":"53","author":"Bartold","year":"2010","journal-title":"Periodontol 2000"},{"key":"R5-14-20240828","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.4103\/0975-7406.100225","article-title":"Statins: A new era in local drug delivery","volume":"4","author":"Elavarasu","year":"2012","journal-title":"J Pharm Bioallied Sci"},{"key":"R6-14-20240828","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.bjp.0704070","article-title":"A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: The role of mevalonic acid","volume":"133","author":"Stalker","year":"2001","journal-title":"Br J Pharmacol"},{"key":"R7-14-20240828","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/adj.12042","article-title":"Simvastatin local drug delivery in smokers with chronic periodontitis: A randomized controlled clinical trial","volume":"58","author":"Rao","year":"2013","journal-title":"Aust Dent J"},{"key":"R8-14-20240828","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1042\/BSR20110118","article-title":"Mechanisms of bone anabolism regulated by statins","volume":"32","author":"Ruan","year":"2012","journal-title":"Biosci Rep"},{"key":"R9-14-20240828","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1902\/jop.2016.160384","article-title":"The effect of locally delivered statins on treating periodontal intrabony defects: A systematic review and meta-analysis","volume":"88","author":"Sinjab","year":"2017","journal-title":"J Periodontol"},{"key":"R10-14-20240828","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-0039-1688522","article-title":"Efficacy of locally administered 1.2% rosuvastatin gel in patients with periodontitis: A randomized placebo controlled clinical trial","volume":"13","author":"Chatterjee","year":"2019","journal-title":"Eur J Dent"},{"key":"R11-14-20240828","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1902\/jop.2016.150706","article-title":"1.2% Rosuvastatin versus 1.2% atorvastatin gel local drug delivery and redelivery in treatment of intrabony defects in chronic periodontitis: A randomized placebo-controlled clinical trial","volume":"87","author":"Pradeep","year":"2016","journal-title":"J Periodontol"},{"key":"R12-14-20240828","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1902\/jop.2016.160399","article-title":"1.2% Rosuvastatin and 1.2% atorvastatin gel local drug delivery and redelivery in the treatment of class II furcation defects: A randomized controlled clinical trial","volume":"88","author":"Garg","year":"2017","journal-title":"J Periodontol"},{"key":"R13-14-20240828","doi-asserted-by":"crossref","first-page":"82","DOI":"10.25259\/JGOH_22_2020","article-title":"Effects of statins as local drug delivery agents in treating chronic periodontitis and their antimicrobial effects using polymerase chain reaction","volume":"3","author":"Singh","year":"2020","journal-title":"J Global Oral Health"},{"key":"R14-14-20240828","doi-asserted-by":"crossref","first-page":"110","DOI":"10.15713\/ins.jcri.272","article-title":"1.2% rosuvastatin gel as a local drug delivery agent in smokers with chronic periodontitis \u2013 A randomized controlled clinical trial","volume":"6","author":"Kanoriya","year":"2019","journal-title":"J Adv Clin Res Insights"},{"key":"R15-14-20240828","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1902\/jop.2015.140631","article-title":"Efficacy of locally delivered 1.2% rosuvastatin gel to non-surgical treatment of patients with chronic periodontitis: A randomized, placebo-controlled clinical trial","volume":"86","author":"Pradeep","year":"2015","journal-title":"J Periodontol"},{"key":"R16-14-20240828","first-page":"74","article-title":"Local drug delivery in periodontal diseases. A review","volume":"6","author":"Ramesh","year":"2016","journal-title":"NitteUniv J Health Sci"},{"key":"R17-14-20240828","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12903-019-0789-2","article-title":"Efficacy of locally-delivered statins adjunct to non-surgical periodontal therapy for chronic periodontitis: A Bayesian network analysis","volume":"19","author":"Cao","year":"2019","journal-title":"BMC Oral Health"},{"key":"R18-14-20240828","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1902\/jop.2016.130227","article-title":"Efficacy of subgingivally delivered 1.2% atorvastatin in the treatment of chronic periodontitis in patients with type 2 diabetes mellitus: A randomized controlled clinical trial","volume":"87","author":"Kumari","year":"2016","journal-title":"J Periodontol"},{"key":"R19-14-20240828","first-page":"153","article-title":"Local drug delivery system in treatement of periodontitis: A review","volume":"3","author":"Singh","year":"2016","journal-title":"J Periodontal Med Clin Prac"}],"container-title":["Indian Journal of Dental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijdr.ijdr_25_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:11:20Z","timestamp":1787757080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijdr.ijdr_25_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijdr.ijdr_25_21","relation":{},"ISSN":["0970-9290"],"issn-type":[{"value":"0970-9290","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}